The board of directors of Lansen Pharmaceutical Holdings Limited hereby announced that Mr. Fritz Heinrich Horlacher ("Mr. Horlacher") has resigned as an Independent Non-executive Director, a member of the Audit Committee and a member of the Remuneration Committee of the Company with effect from 10 February 2022 upon the expiry of current appointment due to his desire to devote more time to his other personal commitments over 10 years of service in the Company. The company also announced that Ms. Chan Ching Har, Eliza ("Ms. Chan") has been appointed as an Independent Non-executive Director and a member of the Audit Committee of the Company with effect from 10 February 2022.